Relmada Therapeutics
RLMD
RLMD
49 hedge funds and large institutions have $3.14M invested in Relmada Therapeutics in 2025 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 7 closing their positions.
Holders
49
Holders Change
+5
Holders Change %
+11.36%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
6
Reduced
13
Closed
7
Calls
$15K
Puts
–
Net Calls
+$15K
Net Calls Change
-$5K
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
SEI Investments
Oaks,
Pennsylvania
| – | – | -36,230 | Closed |
|
|
TSS
52
Two Sigma Securities
New York
| – | – | -14,012 | Closed |
|
|
SG
53
StoneX Group
New York
| – | – | -13,234 | Closed |
|
|
HCP
54
Hexagon Capital Partners
Rogers,
Arkansas
| – | – | -4,000 | Closed |
|
55
Royal Bank of Canada
Toronto,
Ontario, Canada
| $0 | 1 | +1 | New |
|
56
Barclays
London,
United Kingdom
| $0 | 1 | +1 | New |
|